Immunosuppressive effects of intravenous self administration of dihydroetorphine on lymphocyte functions in rats

Acta Pharmacologica Sinica

Volumn 19, Issue 4, 1998, Pages 387-390

  Wu, Wei Ran ^a,c   Zheng, Ji Wang ^b   Li, Feng Yuan ^a   Li, Ying ^b  

^a XI'AN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Dependency (psychology); Dihydroetorphine; Immunosuppression; Interleukin 2; Lymphocytes; Self administration

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CONCANAVALIN A; DIHYDROETORPHINE; INTERLEUKIN 2; LYMPHOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG SELF ADMINISTRATION; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; RAT; REINFORCEMENT; SPLEEN CELL;

ANIMALS; CELL DIVISION; ETORPHINE; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-2; LYMPHOCYTES; MALE; RATS; RATS, WISTAR; SELF ADMINISTRATION; SPLEEN; SUBSTANCE-RELATED DISORDERS;

EID: 2642650335     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bentley KW, Hardy DG. Novel analgesics and molecular rearrangements in the morphine-thebaine group. III. Alcohols of the 6, 14-endo-ethenotetrahydro-oripavine series and derived analogues of N-allylnormorphine and norcodeine. J Am Chem Soc 1967; 89: 3281-92.
2. Blane GF, Boura ALA, Fitzgerald AE, Lister RE. Actions of etorphine hydrochloride (M99): a potent morphine-like agent. Br J Pharmacol Chemother 1967; 30: 11-22.
3. Huang M, Qin BY. Physical dependence of dihydroetorphine in mice and monkeys. Acta Pharmacol Sin 1982; 3: 81-4.
4. Wang DX, Liu YS, Qin BY. Experimental therapeutic effects of dihydroetorphine in morphine-dependent rats and monkeys. Chin J Pharmacol Toxicol 1992; 6: 36-40.
5. Qin BY. Advances of dihydroetorphine: from analgesia to detoxification. Drug Dev Res 1996; 39: 131-4.
6. Liu ZM, Cao JQ, Shi F, Cai ZJ. An epidemiological study on dihydroetorphine abuse. Chin Bull Drug Depend 1995; 4: 223-31.
7. Spealman RD, Goldberg SR. Drug self administration by laboratory animals: control by schedules of reinforcement. Annu Rev Pharmacol Toxicol 1978; 18: 313-39.
8. Wang WP, Xie L, Zheng JW, Cai ZJ. A continuous self administration model under fixed ratio in rats. Chin Bull Drug Depend 1994; 3: 214-7.
9. Bayer BM, Daussin S, Hernandez M, Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 1990; 29: 369-74.
10. Bunjes D, Hardt C, Rollinghoff M, Wagner H. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol 1981; 11: 657-61.
11. Wu WR, Li Y, Zhang KR, Wang GL, Xie L, Bai HQ. Effects of dihydroetorphine on immune functions in rats treated by automatical intravenous injection. Chin Bull Drug Depend 1998; 7: in press.
12. Wu WR, Zheng JW, Li FY, Li Y, Zhang KR, Bai HQ. Involvement of μ-opioid receptors and α-adrenoceptors in the immunomodulatory effects of dihydroetorphine. Eur J Pharmacol 1998; in press.